Assistant Professor Cody Wenthur has been selected for one of UW–Madison’s highest faculty honors.
psychoactive pharmaceutical research
The School’s PharmD Students Get Ahead in Industry and Psychiatric Pharmacy
Through two new concentrations in the PharmD program, student pharmacists receive specialized training to advance their careers.
Pharmacy Experts Webinar: Psychedelic Medicine, Pharmacy & Society
Watch as Associate Professor Lucas Richert, of the Social and Administrative Sciences Division, and Professor Paul Hutson and Assistant Professor Cody Wenthur, both of the Pharmacy Practice and Translational Research Division, discuss where psychedelic research is today, what projects are underway here at UW–Madison, and how the role of pharmacists factors in.
New PharmD Options Offer Specialized Training in Industry and Psychiatric Pharmacy
The two first-of-their-kind Paths of Distinction in psychiatric pharmacy and applied drug development give UW–Madison student pharmacists a competitive edge.
Equity in Psychedelic Therapies
As psychoactive substances gain therapeutic evidence, Assistant Professor Cody Wenthur aims to reverse underrepresentation of minorities in clinical studies.
New Center for Psychoactive Substances Research Accelerates the Search for Therapeutics
Housed at the School of Pharmacy, the Transdisciplinary Center for Research in Psychoactive Substances leverages clinical and multidisciplinary expertise in emerging field of psychedelic-assisted therapy.
UW–Madison Pioneers Master’s Program in Therapeutic Use of Psychoactive Drugs
In response to a resurgence in research and a need for a highly trained workforce, the School of Pharmacy introduces a new MS in Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation — the only master’s program of its kind in the U.S.
How Important is the ‘Psychedelic’ in Psychedelic Drug Therapies?
A new study led by School of Pharmacy researchers seeks to separate the psychedelic experience from the drugs’ therapeutic effects.